UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 23,
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more aTyr Pharma Charts.
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more aTyr Pharma Charts.

Atyr Pharma Inc News

aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
Thursday 2 May 2024 (20 hours ago) • GlobeNewswire Inc.
aTyr Pharma to Participate in April Investor Conferences
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
Wednesday 21 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
Monday 29 January 2024 (3 months ago) • GlobeNewswire Inc.
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
Thursday 18 January 2024 (3 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 9 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 9 January 2024 (4 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Tuesday 2 January 2024 (4 months ago) • Edgar (US Regulatory)

More Atyr Pharma Inc News Articles